For two weeks in January, 16 junior and senior graphic design majors joined two professors and headed to London for two weeks ...

A teacher-incentive program in South Carolina has led to striking long-term benefits for students, including lower rates of ...

Lian indicated the oral VK2735 program is expected to advance into Phase III for obesity, with initiation targeted for the third quarter of 2026. "We currently expect to initiate this program in the ...

Boutique MedTech CRO gains access to unified eClinical platform with wholesale pricing, training, and joint marketing ...

On February 6, 2026, HTX officially launched the industry's first "New Funds Bonus Trial Program", a strategic initiative designed to reward actual net new funds deposited on the platform. Moving ...

A teacher-incentive program in South Carolina has led to striking long-term benefits for students, including lower rates of ...

Peer-reviewed Phase 2 Results Inform Ongoing Phase 3/Pivotal Trial of Celeste® in Parkinson’s Disease The Phase 2 study ...

Strong gold price to have material impact on economics: Since the Updated Scoping Study was released in May 2025 using a gold ...

Community collaboration is just as essential as a tailored clinical trial design to best investigate the effects of a disease on a specific patient population, Amir Fathi, MD, director of the leukemia ...

Luana R. C. Pesco Koplowitz, M.D., Ph.D., Founder, President and Chief Scientific Officer of DUCK FLATS Pharma commented, “It is rewarding to engage with Oragenics on overall development strategy for ...

Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a precision guided biotech/life sciences company focused on advancing the clinical development programs of novel and potentially ...

Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced ...